|
COL4A3BP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.256000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.403240E-01 |
| Normal-vs-Stage2 |
5.523400E-01 |
| Normal-vs-Stage3 |
5.777200E-01 |
| Normal-vs-Stage4 |
2.814400E-01 |
| Stage1-vs-Stage2 |
2.117600E-01 |
| Stage1-vs-Stage3 |
2.889800E-01 |
| Stage1-vs-Stage4 |
7.824600E-01 |
| Stage2-vs-Stage3 |
9.464600E-01 |
| Stage2-vs-Stage4 |
2.726200E-01 |
| Stage3-vs-Stage4 |
2.545200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.685600E-01 |
| Normal-vs-AfricanAmerican |
4.495400E-01 |
| Normal-vs-Asian |
6.736800E-01 |
| Caucasian-vs-AfricanAmerican |
6.751400E-01 |
| Caucasian-vs-Asian |
6.275400E-01 |
| AfricanAmerican-vs-Asian |
5.806800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.498800E-01 |
| Normal-vs-Female |
2.590000E-01 |
| Male-vs-Female |
7.587700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.586800E-01 |
| Normal-vs-Extreme_Weight |
1.602820E-01 |
| Normal-vs-Obese |
8.260200E-01 |
| Normal-vs-Extreme_Obese |
6.239000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.941800E-01 |
| Normal_Weight-vs-Obese |
5.050400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.787800E-01 |
| Extreme_Weight-vs-Obese |
2.191400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.819400E-01 |
| Obese-vs-Extreme_Obese |
6.373800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.893000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.189800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.767600E-02 |
| Normal-vs-Age(81-100Yrs) |
8.158800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.728230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.559000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.800600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.372400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.944400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.498200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.254220E-01 |
| Normal-VS-Type2 PRCC |
3.182000E-01 |
| Normal-VS-KIRP CIMP |
4.512400E-02 |
| Normal-VS-Unclassified PRCC |
2.902400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.473900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.116850E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.601600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.307800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.235800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.742100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.225200E-01 |
| Normal-vs-N1 |
5.029000E-01 |
| Normal-vs-N2 |
9.250600E-01 |
| N0-vs-N1 |
5.463800E-01 |
| N0-vs-N2 |
9.954600E-01 |
| N1-vs-N2 |
7.180800E-01 |
|
|
